Supplemental material
Report
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
, , , , 
, , , & show all
Akira HarazonoDivision of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japanhttp://orcid.org/0000-0002-0307-7404View further author information
http://orcid.org/0000-0002-0307-7404View further author information, , Masato KiyoshiDivision of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japanhttp://orcid.org/0000-0002-5969-8138View further author information
http://orcid.org/0000-0002-5969-8138View further author information, & show allRelated Research Data
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life.
Source:
Frontiers Media SA
HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.
Source:
Spandidos Publications
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
Source:
Nature Publishing Group
Monoclonal Antibodies: A Review
Source:
Bentham Science Publishers Ltd.
Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab
Source:
Springer Science and Business Media LLC
Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
Source:
Elsevier BV
Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
Source:
Proceedings of the National Academy of Sciences
Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG
Source:
Wiley
Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage
Source:
Elmer Press, Inc.
THE COVALENT STRUCTURE OF AN ENTIRE γG IMMUNOGLOBULIN MOLECULE
Source:
Proceedings of the National Academy of Sciences
Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions.
Source:
Elsevier BV
Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
Source:
Frontiers Media SA
Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities
Source:
Public Library of Science (PLoS)
Sequence-to-structure dependence of isolated IgG Fc complex biantennary N-glycans: a molecular dynamics study.
Source:
Oxford University Press (OUP)
Galactosylation variations in marketed therapeutic antibodies
Source:
Informa UK Limited
Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.
Source:
Informa UK Limited
Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.
Source:
Wiley
IgG Fc engineering to modulate antibody effector functions
Source:
SpringerOpen
Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions
Source:
American Chemical Society (ACS)
The Structural Role of Antibody N-Glycosylation in Receptor Interactions
Source:
Elsevier BV
Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins
Source:
Elsevier BV
Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies.
Source:
Japanese Society of Toxicologic Pathology
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
Source:
American Society of Clinical Oncology (ASCO)
Fragmentation of negative ions from carbohydrates: part 2. Fragmentation of high-mannose N-linked glycans.
Source:
American Chemical Society (ACS)
A single amino acid distorts the Fc γ receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a.
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Linking provided by
